127 related articles for article (PubMed ID: 8785034)
1. Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis.
Fieren MW
Blood Purif; 1996; 14(2):179-87. PubMed ID: 8785034
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages.
Fieren MW; van den Bemd GJ; Ben-Efraim S; Bonta IL
Immunol Lett; 1992 Jan; 31(1):85-90. PubMed ID: 1548034
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory fluids regulate TNF-alpha, but not IL-1 beta, production by human peritoneal macrophages. A study of patients on continuous ambulatory peritoneal dialysis with peritonitis.
Hart PH; Jones CA; Finlay-Jones JJ
J Leukoc Biol; 1993 Mar; 53(3):309-19. PubMed ID: 7681094
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis show a differential secretion of prostanoids and interleukin-1 beta.
Fieren MW; van den Bemd GJ; Bonta IL
Prostaglandins Leukot Essent Fatty Acids; 1992 Sep; 47(1):23-8. PubMed ID: 1438464
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis.
Rashid G; Korzets Z; Bernheim J
Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumour necrosis factor during peritonitis.
Fieren MW; van den Bemd GJ; Bonta IL; Ben-Efraim S
J Clin Lab Immunol; 1991 Jan; 34(1):1-9. PubMed ID: 1667936
[TBL] [Abstract][Full Text] [Related]
7. Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeability.
Zemel D; Krediet RT
Blood Purif; 1996; 14(2):198-216. PubMed ID: 8785036
[TBL] [Abstract][Full Text] [Related]
8. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
[TBL] [Abstract][Full Text] [Related]
9. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
[TBL] [Abstract][Full Text] [Related]
10. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.
Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC
Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1 beta in vitro during infectious peritonitis.
Fieren MW; Van den Bemd GJ; Bonta IL
Eur J Clin Invest; 1990 Aug; 20(4):453-7. PubMed ID: 2121505
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitis.
Fieren MW; van den Bemd GJ; Bonta IL
Adv Perit Dial; 1990; 6():120-2. PubMed ID: 1982787
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
[TBL] [Abstract][Full Text] [Related]
14. [Milrinone suppresses TNF-alpha and IL-1 beta release in mouse peritoneal macrophages].
Masaki Y; Sato W; Kayaba M; Enzan K; Suzuki M
Masui; 1995 Jun; 44(6):800-4. PubMed ID: 7637154
[TBL] [Abstract][Full Text] [Related]
15. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M
Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614
[TBL] [Abstract][Full Text] [Related]
16. Reduced secretion of IL-1 beta by peritoneal cells from patients on continuous ambulatory peritoneal dialysis.
Hart PH; Jones CA; Jones KL; Finlay-Jones JJ
Immunol Cell Biol; 1993 Apr; 71 ( Pt 2)():99-107. PubMed ID: 8486401
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism.
McGregor SJ; Topley N; Jörres A; Speekenbrink AB; Gordon A; Gahl GM; Junor BJ; Briggs JD; Brock JH
Kidney Int; 1996 Feb; 49(2):525-33. PubMed ID: 8821840
[TBL] [Abstract][Full Text] [Related]
18. Disparate cytochemical characteristics and production of cytokines and prostaglandin E2 by human mononuclear phagocytes from the blood, lung, and peritoneal cavity.
Friedlander MA; Hilbert CM; Wu YC; Finegan CK; Rich EA
J Lab Clin Med; 1994 Apr; 123(4):574-84. PubMed ID: 8145006
[TBL] [Abstract][Full Text] [Related]
19. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency.
Klínger J; Enríquez J; Arturo JA; Delgado M; Avila G; Ceballos O
Adv Perit Dial; 2002; 18():170-6. PubMed ID: 12402613
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis.
Betjes MG; Tuk CW; Struijk DG; Krediet RT; Arisz L; Hart M; Beelen RH
J Infect Dis; 1993 Nov; 168(5):1202-10. PubMed ID: 8228354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
